LearnGlossaryMarketStocksSuperinvestorsSign in

CPRX

Catalyst Pharmaceuticals, Inc.

Healthcare · $3.9B market cap

Verdict

We can't put a fair value on CPRX right now. It doesn't appear to be actively trading. It may have been delisted, merged or renamed, so we don't value it.

Business quality

5 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth35.9% a year✓
Equity per share growth22.9% a year✓
Sales growth37.7% a year✓
Free cash flow growth35.9% a year✓
Return on invested capital19.1%✓

Follow CPRX

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds CPRX. In Q2 2026, 1 sold out. Who we track

Third Avenue Management

Third Avenue Management · as of Q2 2026

$6.6M

210,161 shares

Moves in Q2 2026

Sold out: Terry Smith

Insider activity

Since Jul 15, 2026: no open-market purchases and 100 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Kalb Michael Wayne

Chief Financial Officer · 2026-07-15

D-Return

$4.3M

Kalb Michael Wayne

Chief Financial Officer · 2026-07-15

D-Return

$430K

Harper Molly

director · 2026-07-15

D-Return

5,468 shares

Harper Molly

director · 2026-07-15

D-Return

$412K

Harper Molly

director · 2026-07-15

D-Return

$491K

Show all 100 other filings

Harper Molly

director · 2026-07-15

D-Return

$418K

Harper Molly

director · 2026-07-15

D-Return

$279K

Harper Molly

director · 2026-07-15

D-Return

$141K

Harper Molly

director · 2026-07-15

D-Return

$72K

Harper Molly

director · 2026-07-15

D-Return

$116K

Andrews William T.

Chief Medical Officer · 2026-07-15

D-Return

29,776 shares

Andrews William T.

Chief Medical Officer · 2026-07-15

D-Return

$2.2M

Andrews William T.

Chief Medical Officer · 2026-07-15

D-Return

$3.1M

Andrews William T.

Chief Medical Officer · 2026-07-15

D-Return

$73K

Daly Richard J

President and CEO · 2026-07-15

D-Return

115,283 shares

Daly Richard J

President and CEO · 2026-07-15

D-Return

$8.7M

Daly Richard J

President and CEO · 2026-07-15

D-Return

$10.4M

Daly Richard J

President and CEO · 2026-07-15

D-Return

$18.2M

Daly Richard J

President and CEO · 2026-07-15

D-Return

$279K

Daly Richard J

President and CEO · 2026-07-15

D-Return

$141K

Daly Richard J

President and CEO · 2026-07-15

D-Return

$103K

Daly Richard J

President and CEO · 2026-07-15

D-Return

$155K

Daly Richard J

President and CEO · 2026-07-15

D-Return

$8.5M

Sundaram Preethi

Chief Strategy Officer · 2026-07-15

D-Return

32,257 shares

Sundaram Preethi

Chief Strategy Officer · 2026-07-15

D-Return

$2.4M

Sundaram Preethi

Chief Strategy Officer · 2026-07-15

D-Return

$2.9M

Sundaram Preethi

Chief Strategy Officer · 2026-07-15

D-Return

$2.0M

Sundaram Preethi

Chief Strategy Officer · 2026-07-15

D-Return

$1.3M

Sundaram Preethi

Chief Strategy Officer · 2026-07-15

D-Return

$477K

Sundaram Preethi

Chief Strategy Officer · 2026-07-15

D-Return

$1.2M

Sundaram Preethi

Chief Strategy Officer · 2026-07-15

D-Return

$1.7M

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

32,257 shares

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

$2.4M

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

$2.9M

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

$2.4M

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

$1.6M

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

$954K

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

$684K

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

$705K

Del Carmen Jeffrey

Chief Commercial Officer · 2026-07-15

D-Return

$452K

DENKHAUS DONALD A

director · 2026-07-15

D-Return

5,468 shares

DENKHAUS DONALD A

director · 2026-07-15

D-Return

$412K

DENKHAUS DONALD A

director · 2026-07-15

D-Return

$491K

DENKHAUS DONALD A

director · 2026-07-15

D-Return

$418K

DENKHAUS DONALD A

director · 2026-07-15

D-Return

$279K

DENKHAUS DONALD A

director · 2026-07-15

D-Return

$141K

DENKHAUS DONALD A

director · 2026-07-15

D-Return

$103K

DENKHAUS DONALD A

director · 2026-07-15

D-Return

$155K

DENKHAUS DONALD A

director · 2026-07-15

D-Return

$15.7M

MCENANY PATRICK J

director · 2026-07-15

D-Return

10,540 shares

MCENANY PATRICK J

director · 2026-07-15

D-Return

$795K

MCENANY PATRICK J

director · 2026-07-15

D-Return

$921K

MCENANY PATRICK J

director · 2026-07-15

D-Return

$1.0M

MCENANY PATRICK J

director · 2026-07-15

D-Return

$5.1M

MCENANY PATRICK J

director · 2026-07-15

D-Return

$1.9M

MCENANY PATRICK J

director · 2026-07-15

D-Return

$1.4M

MCENANY PATRICK J

director · 2026-07-15

D-Return

$3.4M

MCENANY PATRICK J

director · 2026-07-15

D-Return

$131.4M

Russo Gregg

Chief HR Officer · 2026-07-15

D-Return

6,197 shares

Russo Gregg

Chief HR Officer · 2026-07-15

D-Return

$467K

Russo Gregg

Chief HR Officer · 2026-07-15

D-Return

$473K

Russo Gregg

Chief HR Officer · 2026-07-15

D-Return

$159K

Russo Gregg

Chief HR Officer · 2026-07-15

D-Return

$233K

Russo Gregg

Chief HR Officer · 2026-07-15

D-Return

$15K

Thompson Tamar

director · 2026-07-15

D-Return

5,468 shares

Thompson Tamar

director · 2026-07-15

D-Return

$412K

Thompson Tamar

director · 2026-07-15

D-Return

$491K

Thompson Tamar

director · 2026-07-15

D-Return

$418K

Thompson Tamar

director · 2026-07-15

D-Return

$464K

Thompson Tamar

director · 2026-07-15

D-Return

$119K

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

47,826 shares

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

$3.6M

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

$4.3M

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

$3.5M

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

$2.7M

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

$1.3M

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

$941K

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

$835K

Miller Steve

Chief Op. & Scientific Officer · 2026-07-15

D-Return

$34.5M

Tierney David S

director · 2026-07-15

D-Return

5,468 shares

Tierney David S

director · 2026-07-15

D-Return

$412K

Tierney David S

director · 2026-07-15

D-Return

$491K

Tierney David S

director · 2026-07-15

D-Return

$418K

Tierney David S

director · 2026-07-15

D-Return

$279K

Tierney David S

director · 2026-07-15

D-Return

$141K

Tierney David S

director · 2026-07-15

D-Return

$103K

Tierney David S

director · 2026-07-15

D-Return

$155K

Tierney David S

director · 2026-07-15

D-Return

$12.1M

Curran Daniel J.

director · 2026-07-15

D-Return

5,468 shares

Curran Daniel J.

director · 2026-07-15

D-Return

$412K

Curran Daniel J.

director · 2026-07-15

D-Return

$845K

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

29,776 shares

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

$2.2M

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

$2.7M

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

$2.1M

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

$1.3M

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

$954K

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

$684K

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

$612K

Elsbernd Brian

Chief Legal Officer · 2026-07-15

D-Return

$7.6M

About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Jul 15, 2026. How the Payback Price works